Skip to main content

Advertisement

Log in

Beyond Giant Cell Arteritis and Takayasu’s Arteritis: Secondary Large Vessel Vasculitis and Vasculitis Mimickers

  • Recent Advances in Large Vessel Vasculitis (C Dejaco and C Duftner, Section Editors)
  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

To provide an overview of mimickers of large vessel vasculitis (LVV), by the main presenting manifestation, i.e., systemic, vascular, and cranial manifestations.

Recent Findings

The main differential diagnoses in patients with giant cell arteritis (GCA) and Takayasu arteritis (TAK) presenting with systemic manifestations (i.e., fever, anorexia, weight loss, night sweats, arthralgia/myalgia, and/or increased inflammatory indexes) are neoplastic, infectious, or other inflammatory conditions. In patients with vascular manifestations (such as peripheral ischemia, vascular stenoses, or aneurysms), atherosclerosis and non-inflammatory vascular diseases should be excluded. In those presenting with predominant cranial symptoms (i.e., temporal headache, jaw claudication, scalp tenderness, transient or permanent vision loss), other causes of headache, cerebrovascular accidents, optic neuropathy, and neuromuscular syndromes need to be considered.

Summary

The diagnosis of LVV maybe challenging, especially when patients present with atypical or incomplete clinical forms. In these cases, a multidisciplinary approach is strongly recommended.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65(1):1–11.

    Article  CAS  PubMed  Google Scholar 

  2. Gribbons KB, Ponte C, Carette S, Craven A, Cuthbertson D, Hoffman GS, et al. Patterns of arterial disease in Takayasu's arteritis and giant cell arteritis. Arthritis Care Res. 2019.

  3. Furuta S, Cousins C, Chaudhry A, Jayne D. Clinical features and radiological findings in large vessel vasculitis: are Takayasu arteritis and giant cell arteritis 2 different diseases or a single entity? J Rheumatol. 2015;42(2):300–8.

    Article  PubMed  Google Scholar 

  4. Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990;33(8):1129–34.

    Article  CAS  PubMed  Google Scholar 

  5. Zarka F, Veillette C, Makhzoum JP. A review of primary vasculitis mimickers based on the Chapel Hill consensus classification. Int J Rheumatol. 2020;2020:8392542.

    PubMed  PubMed Central  Google Scholar 

  6. Dejaco C, Duftner C, Buttgereit F, Matteson EL, Dasgupta B. The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease. Rheumatology (Oxford). 2017;56(4):506–15.

    CAS  Google Scholar 

  7. de Souza AW, de Carvalho JF. Diagnostic and classification criteria of Takayasu arteritis. J Autoimmun. 2014;48-49:79–83.

    Article  PubMed  CAS  Google Scholar 

  8. Muratore F, Crescentini F, Spaggiari L, Pazzola G, Casali M, Boiardi L, et al. Aortic dilatation in patients with large vessel vasculitis: a longitudinal case control study using PET/CT. Semin Arthritis Rheum. 2019;48(6):1074–82.

    Article  PubMed  Google Scholar 

  9. Quinn KA, Gribbons KB, Carette S, Cuthbertson D, Khalidi NA, Koening CL, et al. Patterns of clinical presentation in Takayasu's arteritis. Semin Arthritis Rheum. 2020;50(4):576–81.

    Article  PubMed  Google Scholar 

  10. Prieto-Gonzalez S, Arguis P, Garcia-Martinez A, Espigol-Frigole G, Tavera-Bahillo I, Butjosa M, et al. Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography. Ann Rheum Dis. 2012;71(7):1170–6.

    Article  PubMed  Google Scholar 

  11. Ostberg G. Temporal arteritis in large necropsy series. Ann Rheum Dis. 1971;30:224–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Berti A, Campochiaro C, Cavalli G, Pepe G, Praderio L, Sabbadini MG, et al. Giant cell arteritis restricted to the limb arteries: an overlooked clinical entity. Autoimmun Rev. 2015;14(4):352–7.

    Article  PubMed  Google Scholar 

  13. Comarmond C, Biard L, Lambert M, Mekinian A, Ferfar Y, Kahn JE, et al. Long-term outcomes and prognostic factors of complications in Takayasu arteritis: a multicenter study of 318 patients. Circulation. 2017;136(12):1114–22.

    Article  PubMed  Google Scholar 

  14. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33(8):1122–8.

    Article  CAS  PubMed  Google Scholar 

  15. Narvaez J, Estrada P, Lopez-Vives L, Ricse M, Zacarias A, Heredia S, et al. Prevalence of ischemic complications in patients with giant cell arteritis presenting with apparently isolated polymyalgia rheumatica. Semin Arthritis Rheum. 2015;45(3):328–33.

    Article  PubMed  Google Scholar 

  16. Czihal MTF, Förster S, Rademacher A, Schulze-Koops H, Hoffmann U. Fever of unknown origin as initial manifestation of large vessel giant cell arteritis: diagnosis by colour-coded sonography and 18-FDG-PET. Clin Exp Rheumatol. 2010;28(4):549–52.

    CAS  PubMed  Google Scholar 

  17. Kermani TA, Schmidt J, Crowson CS, Ytterberg SR, Hunder GG, Matteson EL, et al. Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum. 2012;41(6):866–71.

    Article  CAS  PubMed  Google Scholar 

  18. Matteson EL, Dejaco C. Polymyalgia Rheumatica. Ann Intern Med. 2017;166(9):ITC65–80.

    Article  PubMed  Google Scholar 

  19. Deshayes S, Liozon E, Chanson N, Sacre K, Moulinet T, Blanchard-Delaunay C, et al. Concomitant association of giant cell arteritis and malignancy: a multicenter retrospective case-control study. Clin Rheumatol. 2019;38(5):1243–9.

    Article  CAS  PubMed  Google Scholar 

  20. Zenone T. Fever of unknown origin in rheumatic diseases. Infect Dis Clin N Am. 2007;21(4):1115–35 x-xi.

    Article  Google Scholar 

  21. Wang Q, Li YM, Li Y, Hua FC, Wang QS, Zhang XL, et al. (18)F-FDGPET/CT in fever of unknown origin and inflammation of unknown origin: a Chinese multi-center study. Eur J Nucl Med Mol Imaging. 2019;46(1):159–65.

    Article  PubMed  Google Scholar 

  22. Revest M, Decaux O, Cazalets C, Verohye JP, Jego P, Grosbois B. Thoracic infectious aortitis: microbiology, pathophysiology and treatment. Rev Med Interne. 2007;28(2):108–15.

    Article  CAS  PubMed  Google Scholar 

  23. Bossone E, Pluchinotta FR, Andreas M, Blanc P, Citro R, Limongelli G, et al. Aortitis. Vasc Pharmacol. 2016;80:1–10.

    Article  CAS  Google Scholar 

  24. Osler W. The Gulstonian Lectures, on Malignant Endocarditis. Br Med J. 1885;14;1(1263):522–6.

    Article  Google Scholar 

  25. Katabathina VS, Restrepo CS. Infectious and noninfectious aortitis: cross-sectional imaging findings. Semin Ultrasound CT MR. 2012;33(3):207–21.

    Article  PubMed  Google Scholar 

  26. Delaval L, Goulenok T, Achouh P, Saadoun D, Gaudric J, Pellenc Q, et al. New insights on tuberculous aortitis. J Vasc Surg. 2017;66(1):209–15.

    Article  PubMed  Google Scholar 

  27. Allins ADWW, Cossman DV, Gold RN, Hiatt JR. Tuberculous infection of the descending thoracic and abdominal aorta: case report and literature review. Ann Vasc Surg. 1999;13(4):439–44.

    Article  CAS  PubMed  Google Scholar 

  28. Long RGR, Greenberg H, Safneck J, Hershfield E. Tuberculous mycotic aneurysm of the aorta: review of published medical and surgical experience. Chest. 1999;115(2):522–31.

    Article  CAS  PubMed  Google Scholar 

  29. Khasnis AME. Mimics of primary systemic vasculitides. Int J Clin Rheumatol. 2009;4(5):597–609.

    Article  Google Scholar 

  30. Heggtveit HA. Syphilitic aortitis. A clinicopathologic autopsy study of 100 cases, 1950 to 1960. Circulation. 1964;29:346–55.

    Article  CAS  PubMed  Google Scholar 

  31. Jackman JD Jr, Radolf JD. Cardiovascular syphilis. Am J Med. 1989;87:425–33.

    Article  PubMed  Google Scholar 

  32. Vlahakes GJHG, Mark EJ. Case records of the massachusetts general hospital. Weekly clinicopathological exercises. Case 10–1998. A 46-year-old man with chest pain and coronary ostial stenosis. N Engl J Med. 1998;338(13):897–903.

    Article  Google Scholar 

  33. Kimura FSH, Sakai F, Nishii N, Tohda J, Fujimura M, Haruta S, et al. Computed tomographic findings of syphilitic aortitis. Cardiovasc Intervent Radiol. 2004;27:179–81.

    Article  PubMed  Google Scholar 

  34. Paulo N, Cascarejo J, Vouga L. Syphilitic aneurysm of the ascending aorta. Interact Cardiovasc Thorac Surg. 2012;14(2):223–5.

    Article  PubMed  Google Scholar 

  35. Oz MC, Brener BJ, Buda JA, Todd G, Brenner RW, Goldenkranz RJ, et al. A ten-year experience with bacterial aortitis. J Vasc Surg. 1989;10(4):439–49.

    Article  CAS  PubMed  Google Scholar 

  36. Miller DV, Oderich GS, Aubry MC, Panneton JM, Edwards WD. Surgical pathology of infected aneurysms of the descending thoracic and abdominal aorta: clinicopathologic correlations in 29 cases (1976 to 1999). Hum Pathol. 2004;35(9):1112–20.

    Article  PubMed  Google Scholar 

  37. Leon LR Jr, Rodriguez HE, Labropoulos N, Littooy FN, Psalms SB. Aortitis and bacterial endocarditis. Vascular. 2008;16(1):53–8.

    Article  PubMed  Google Scholar 

  38. Rousselin C, Pontana F, Puech P, Lambert M. Differential diagnosis of aortitis. Rev Med Interne. 2016;37(4):256–63.

    Article  CAS  PubMed  Google Scholar 

  39. Restrepo CSOD, Suri R, Vargas D. Aortitis: imaging spectrumof the infectious and inflammatory conditions of the aorta. Radiographics. 2011;31:435–51.

    Article  PubMed  Google Scholar 

  40. Hoogendoorn EH, Oyen WJ, van Dijk AP, van der Meer JW. Pneumococcal aortitis, report of a case with emphasis on the contribution to diagnosis of positron emission tomography using fluorinated deoxyglucose. Clin Microbiol Infect. 2003;9(1):73–6.

    Article  CAS  PubMed  Google Scholar 

  41. Stone JH, Khosroshahi A, Deshpande V, Stone JR. IgG4-related systemic disease accounts for a significant proportion of thoracic lymphoplasmacytic aortitis cases. Arthritis Care Res. 2010;62(3):316–22.

    Article  Google Scholar 

  42. Perugino CA, Wallace ZS, Meyersohn N, Oliveira G, Stone JR, Stone JH. Large vessel involvement by IgG4-related disease. Medicine (Baltimore). 2016;95(28):e3344.

    Article  CAS  Google Scholar 

  43. Inoue D, Yoshida K, Yoneda N, Ozaki K, Matsubara T, Nagai K, et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore). 2015;94(15):e680.

    Article  CAS  Google Scholar 

  44. Kasashima F, Kawakami K, Matsumoto Y, Endo M, Kasashima S, Kawashima A. IgG4-related arterial disease. Ann Vasc Dis. 2018;11(1):72–7.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Walker DI, Bloor K, Williams G, Gillie I. Inflammatory aneurysms of the abdominal aorta. Br J Surg. 1972;59:609–14.

    Article  CAS  PubMed  Google Scholar 

  46. Kasashima S, Zen Y, Kawashima A, Endo M, Matsumoto Y, Kasashima F. A new clinicopathological entity of IgG4-related inflammatory abdominal aortic aneurysm. J Vasc Surg. 2009;49(5):1264–71.

  47. Fatima J, Gota C, Clair DG, Billings SD, Gornik HL. Inflammatory abdominal aortic aneurysm with retroperitoneal fibrosis. Circulation. 2014;130(15):1300–2.

    Article  PubMed  Google Scholar 

  48. Berti A, Della-Torre E, Gallivanone F, Canevari C, Milani R, Lanzillotta M, et al. Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease. Rheumatology (Oxford). 2017;56(12):2084–92.

    Article  CAS  Google Scholar 

  49. Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25(9):1181–92.

    Article  PubMed  Google Scholar 

  50. Veyssier-Belot C, Cacoub P, Caparros-Lefebvre D, Wechsler J, Brun B, Remy M, et al. Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases. Medicine (Baltimore). 1996;75(3):157–69.

    Article  CAS  Google Scholar 

  51. Cavalli G, Guglielmi B, Berti A, Campochiaro C, Sabbadini MG, Dagna L. The multifaceted clinical presentations and manifestations of Erdheim-Chester disease: comprehensive review of the literature and of 10 new cases. Ann Rheum Dis. 2013;72(10):1691–5.

    Article  PubMed  Google Scholar 

  52. Haroche J, Arnaud L, Amoura Z. Erdheim-Chester disease. Curr Opin Rheumatol. 2012;24(1):53–9.

    Article  PubMed  Google Scholar 

  53. Pegoraro F, Papo M, Maniscalco V, Charlotte F, Haroche J, Vaglio A. Erdheim-Chester disease: a rapidly evolving disease model. Leukemia. 2020;34:2840–57.

    Article  CAS  PubMed  Google Scholar 

  54. Berti AFM, Ferrero E, Dagna L. Cardiovascular manifestations of Erdheim-Chester disease. Clin Exp Rheumatol. 2015;33(Suppl 89):S155–63.

    Google Scholar 

  55. Haroche J, Cluzel P, Toledano D, Montalescot G, Touitou D, Grenier PA, et al. Images in cardiovascular medicine. Cardiac involvement in Erdheim-Chester disease: magnetic resonance and computed tomographic scan imaging in a monocentric series of 37 patients. Circulation. 2009;119(25):e597–8.

    Article  PubMed  Google Scholar 

  56. Ghotra AS, Thompson K, Lopez-Mattei J, Bawa D, Hernandez R, Banchs J, et al. Cardiovascular manifestations of Erdheim-Chester disease. Echocardiography. 2019;36(2):229–36.

    Article  PubMed  Google Scholar 

  57. Haroche J, Amoura Z, Dion E, Wechsler B, Costedoat-Chalumeau N, Cacoub P, et al. Cardiovascular involvement, an overlooked feature of Erdheim-Chester disease: report of 6 new cases and a literature review. Medicine (Baltimore). 2004;83(6):371–92.

    Article  Google Scholar 

  58. Brun AL, Touitou-Gottenberg D, Haroche J, Toledano D, Cluzel P, Beigelman-Aubry C, et al. Erdheim-Chester disease: CT findings of thoracic involvement. Eur Radiol. 2010;20(11):2579–87.

    Article  PubMed  Google Scholar 

  59. Mazlumzadeh M, Matteson EL. Cogan's syndrome: an audiovestibular, ocular, and systemic autoimmune disease. Rheum Dis Clin N Am. 2007;33(4):855–74 vii-viii.

    Article  Google Scholar 

  60. Keser G, Aksu K. Diagnosis and differential diagnosis of large-vessel vasculitides. Rheumatol Int. 2019;39(2):169–85.

    Article  PubMed  Google Scholar 

  61. Miloslavsky EM, Stone JH, Unizony SH. Challenging mimickers of primary systemic vasculitis. Rheum Dis Clin N Am. 2015;41(1):141–60 ix.

    Article  Google Scholar 

  62. Berti A, Bond M, Volpe A, Felicetti M, Bortolotti R, Paolazzi G. Practical approach to vasculitides in adults: an overview of clinical conditions that can mimic vasculitides closely. Beyond Rheumatology. 2020;2(1).

  63. Shirai T, Hilhorst M, Harrison DG, Goronzy JJ, Weyand CM. Macrophages in vascular inflammation--from atherosclerosis to vasculitis. Autoimmunity. 2015;48(3):139–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Alie N, Eldib M, Fayad ZA, Mani V. Inflammation, atherosclerosis, and coronary artery disease: PET/CT for the evaluation of atherosclerosis and inflammation. Clin Med Insights Cardiol. 2014;8(Suppl 3):13–21.

    PubMed  Google Scholar 

  65. Pipitone N, Versari A, Salvarani C. Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update. Rheumatology (Oxford). 2008;47(4):403–8.

    Article  CAS  Google Scholar 

  66. Ponte C, Agueda AF, Luqmani RA. Clinical features and structured clinical evaluation of vasculitis. Best Pract Res Clin Rheumatol. 2018;32(1):31–51.

    Article  CAS  PubMed  Google Scholar 

  67. Squizzato F, Antonello M, Taglialavoro J, Prosdocimi L, Grego F, Lupia M, et al. Clinical impact of routine cardiology consultation Prior to elective carotid endarterectomy in neurologically asymptomatic patients. Eur J Vasc Endovasc Surg. 2020;59(4):536–44.

    Article  PubMed  Google Scholar 

  68. Koster MJ, Matteson EL, Warrington KJ. Large-vessel giant cell arteritis: diagnosis, monitoring and management. Rheumatology (Oxford). 2018;57(suppl_2):ii32–42.

    Article  CAS  Google Scholar 

  69. Plouin PF, Perdu J, La Batide-Alanore A, Boutouyrie P, Gimenez-Roqueplo AP, Jeunemaitre X. Fibromuscular dysplasia. Orphanet J Rare Dis. 2007;2:28.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Olin JW, Froehlich J, Gu X, Bacharach JM, Eagle K, Gray BH, et al. The United States registry for fibromuscular dysplasia: results in the first 447 patients. Circulation. 2012;125(25):3182–90.

    Article  PubMed  Google Scholar 

  71. Olin JW, Gornik HL, Bacharach JM, Biller J, Fine LJ, Gray BH, et al. Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association. Circulation. 2014;129(9):1048–78.

    Article  PubMed  Google Scholar 

  72. Oderich GS, Sullivan TM, Bower TC, Gloviczki P, Miller DV, Babovic-Vuksanovic D, et al. Vascular abnormalities in patients with neurofibromatosis syndrome type I: clinical spectrum, management, and results. J Vasc Surg. 2007;46(3):475–84.

    Article  PubMed  Google Scholar 

  73. Kuivaniemi H, Shibamura H, Arthur C, Berguer R, Cole CW, Juvonen T, et al. Familial abdominal aortic aneurysms: collection of 233 multiplex families. J Vasc Surg. 2003;37(2):340–5.

    Article  PubMed  Google Scholar 

  74. Margolis J, Bilfinger T, Labropoulos N. A right-sided aortic arch and aberrant left subclavian artery with proximal segment hypoplasia. Interact Cardiovasc Thorac Surg. 2012;14(3):370–1.

    Article  PubMed  Google Scholar 

  75. Pillai AK, Iqbal SI, Liu RW, Rachamreddy N, Kalva SP. Segmental arterial mediolysis. Cardiovasc Intervent Radiol. 2014;37(3):604–12.

    Article  PubMed  Google Scholar 

  76. Carmody BJ, Arora S, Avena R, Curry KM, Simpkins J, Cosby K, et al. Accelerated carotid artery disease after high-dose head and neck radiotherapy: is there a role for routine carotid duplex surveillance? J Vasc Surg. 1999;30(6):1045–51.

    Article  CAS  PubMed  Google Scholar 

  77. Sanders RJ, Hammond SL, Rao NM. Diagnosis of thoracic outlet syndrome. J Vasc Surg. 2007;46(3):601–4.

    Article  PubMed  Google Scholar 

  78. Durham JR, Yao JS, Pearce WH, Nuber GM, McCarthy WJ 3rd. Arterial injuries in the thoracic outlet syndrome. J Vasc Surg. 1995;21(1):57–69.

  79. Yang L, Zhang H, Jiang X, Song L, Qin F, Zou Y, et al. Clinical features and outcomes of Takayasu arteritis with neurological symptoms in China: a retrospective study. J Rheumatol. 2015;42(10):1846–52.

    Article  CAS  PubMed  Google Scholar 

  80. Salvarani C, Giannini C, Miller DV, Hunder G. Giant cell arteritis: involvement of intracranial arteries. Arthritis Rheum. 2006;55(6):985–9.

    Article  PubMed  Google Scholar 

  81. Ioannides MA, Eftychiou C, Georgiou GM, Nicolaides E. Takayasu arteritis presenting as epileptic seizures: a case report and brief review of the literature. Rheumatol Int. 2009;29(6):703–5.

    Article  PubMed  Google Scholar 

  82. Solans-Laque R, Bosch-Gil JA, Molina-Catenario CA, Ortega-Aznar A, Alvarez-Sabin J, Vilardell-Tarres M. Stroke and multi-infarct dementia as presenting symptoms of giant cell arteritis: report of 7 cases and review of the literature. Medicine (Baltimore). 2008;87(6):335–44.

    Article  Google Scholar 

  83. Bornstein G, Barshack I, Koren-Morag N, Ben-Zvi I, Furie N, Grossman C. Negative temporal artery biopsy: predictive factors for giant cell arteritis diagnosis and alternate diagnoses of patients without arteritis. Clin Rheumatol. 2018;37(10):2819–24.

    Article  PubMed  Google Scholar 

  84. Breuer GS, Nesher R, Nesher G. Negative temporal artery biopsies: eventual diagnoses and features of patients with biopsy-negative giant cell arteritis compared to patients without arteritis. Clin Exp Rheumatol. 2008;26(6):1103–6.

    CAS  PubMed  Google Scholar 

  85. Smetana GW, Shmerling RH. Does this patient have temporal arteritis? JAMA. 2002;287(1):92–101.

    Article  PubMed  Google Scholar 

  86. Garcia-Garcia J, Ayo-Martin O, Segura T. A case of giant cell arteritis presenting as thunderclap headache. Headache. 2013;53(3):546–7.

    Article  PubMed  Google Scholar 

  87. Jimenez-Jimenez FJ, Garcia-Albea E, Zurdo M, Martinez-Onsurbe P, Ruiz de Villaespesa A. Giant cell arteritis presenting as cluster headache. Neurology. 1998;51(6):1767–8.

    Article  CAS  PubMed  Google Scholar 

  88. Mollan SP, Paemeleire K, Versijpt J, Luqmani R, Sinclair AJ. European headache federation recommendations for neurologists managing giant cell arteritis. J Headache Pain. 2020;21(1):28.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Garcia-Porrua C, Vega Andion J, Gonzalez-Gay MA. Idiopathic lateral sinus thrombosis mimicking giant cell arteritis. J Rheumatol. 2001;28(9):2142–3.

    CAS  PubMed  Google Scholar 

  90. Donadini M, Dentali F, Squizzato A, Ageno W. An unusual case of cerebral vein thrombosis in a patient with giant cell arteritis. Thromb Haemost. 2008;100(3):513–4.

    Article  CAS  PubMed  Google Scholar 

  91. Helliwell T, Muller S, Hider SL, Prior JA, Richardson JC, Mallen CD. Challenges of diagnosis and management of giant cell arteritis in general practice: a multimethods study. BMJ Open. 2018;8(2):e019320.

    Article  PubMed  PubMed Central  Google Scholar 

  92. Prencipe M, Casini AR, Ferretti C, Santini M, Pezzella F, Scaldaferri N, et al. Prevalence of headache in an elderly population: attack frequency, disability, and use of medication. J Neurol Neurosurg Psychiatry. 2001;70(3):377–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  93. Tuckwell K, Collinson N, Dimonaco S, Klearman M, Blockmans D, Brouwer E, et al. Newly diagnosed vs. relapsing giant cell arteritis: baseline data from the GiACTA trial. Semin Arthritis Rheum. 2017;46(5):657–64.

    Article  PubMed  Google Scholar 

  94. Lv J, Zhang Q. Cryptococcal meningitis in a patient with giant cell arteritis. Arch Rheumatol. 2017;32(4):361–4.

    Article  PubMed  PubMed Central  Google Scholar 

  95. Roelcke U, Eschle D, Kappos L, Moschopulos M, Laeng RH, Buettner UW. Meningoradiculitis associated with giant cell arteritis. Neurology. 2002;59(11):1811–2.

    Article  CAS  PubMed  Google Scholar 

  96. Gonzalez-Gay MA, Vazquez-Rodriguez TR, Gomez-Acebo I, Pego-Reigosa R, Lopez-Diaz MJ, Vazquez-Trinanes MC, et al. Strokes at time of disease diagnosis in a series of 287 patients with biopsy-proven giant cell arteritis. Medicine (Baltimore). 2009;88(4):227–35.

    Article  Google Scholar 

  97. Samson M, Jacquin A, Audia S, Daubail B, Devilliers H, Petrella T, et al. Stroke associated with giant cell arteritis: a population-based study. J Neurol Neurosurg Psychiatry. 2015;86(2):216–21.

    Article  PubMed  Google Scholar 

  98. Silver M. Takayasu's arteritis - an unusual cause of stroke in a young patient. West J Emerg Med. 2012;13(6):484–7.

    Article  PubMed  PubMed Central  Google Scholar 

  99. Ungprasert P, Wijarnpreecha K, Koster MJ, Thongprayoon C, Warrington KJ. Cerebrovascular accident in patients with giant cell arteritis: a systematic review and meta-analysis of cohort studies. Semin Arthritis Rheum. 2016;46(3):361–6.

    Article  PubMed  Google Scholar 

  100. Wiszniewska M, Devuyst G, Bogousslavsky J. Giant cell arteritis as a cause of first-ever stroke. Cerebrovasc Dis. 2007;24(2–3):226–30.

    Article  PubMed  Google Scholar 

  101. Maaijwee NA, Rutten-Jacobs LC, Schaapsmeerders P, van Dijk EJ, de Leeuw FE. Ischaemic stroke in young adults: risk factors and long-term consequences. Nat Rev Neurol. 2014;10(6):315–25.

    Article  PubMed  Google Scholar 

  102. Skeik N, Rumery KK, Udayakumar PD, Crandall BM, Warrington KJ, Sullivan TM. Concurrent Takayasu arteritis with common variable immunodeficiency and moyamoya disease. Ann Vasc Surg. 2013;27(2):240 e213–48.

    Article  Google Scholar 

  103. Bond KM, Nasr D, Lehman V, Lanzino G, Cloft HJ, Brinjikji W. Intracranial and extracranial neurovascular manifestations of Takayasu arteritis. AJNR Am J Neuroradiol. 2017;38(4):766–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  104. D'Souza NM, Morgan ML, Almarzouqi SJ, Lee AG. Magnetic resonance imaging findings in giant cell arteritis. Eye (Lond). 2016;30(5):758–62.

    Article  CAS  Google Scholar 

  105. Berlit P, Kraemer M. Cerebral vasculitis in adults: what are the steps in order to establish the diagnosis? Red flags and pitfalls. Clin Exp Immunol. 2014;175(3):419–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  106. Bley TA, Uhl M, Carew J, Markl M, Schmidt D, Peter HH, et al. Diagnostic value of high-resolution MR imaging in giant cell arteritis. AJNR Am J Neuroradiol. 2007;28(9):1722–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  107. Siemonsen S, Brekenfeld C, Holst B, Kaufmann-Buehler AK, Fiehler J, Bley TA. 3T MRI reveals extra- and intracranial involvement in giant cell arteritis. AJNR Am J Neuroradiol. 2015;36(1):91–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  108. Klink T, Geiger J, Both M, Ness T, Heinzelmann S, Reinhard M, et al. Giant cell arteritis: diagnostic accuracy of MR imaging of superficial cranial arteries in initial diagnosis-results from a multicenter trial. Radiology. 2014;273(3):844–52.

    Article  PubMed  Google Scholar 

  109. Miller TR, Shivashankar R, Mossa-Basha M, Gandhi D. Reversible cerebral vasoconstriction syndrome, part 1: epidemiology, pathogenesis, and clinical course. AJNR Am J Neuroradiol. 2015;36(8):1392–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  110. Camara-Lemarroy CR, Lara-Campos JG, Perez-Contreras E, Rodriguez-Gutierrez R, Galarza-Delgado DA. Takayasu's arteritis and posterior reversible encephalopathy syndrome: a case-based review. Clin Rheumatol. 2013;32(3):409–15.

    Article  PubMed  Google Scholar 

  111. Reinhard M, Schmidt D, Hetzel A. Color-coded sonography in suspected temporal arteritis-experiences after 83 cases. Rheumatol Int. 2004;24(6):340–6.

    Article  PubMed  Google Scholar 

  112. Molina Collada J, Ruiz Bravo-Burguillos E, Monjo I, Bonilla G, Fernandez E, Balsa A, et al. Positive ultrasound halo sign of temporal arteries due to amyloidosis. Rheumatology (Oxford). 2019;58(11):2067–9.

    Article  Google Scholar 

  113. Fernandez-Fernandez E, Monjo-Henry I, Bonilla G, Plasencia C, Miranda-Carus ME, Balsa A, et al. False positives in the ultrasound diagnosis of giant cell arteritis: some diseases can also show the halo sign. Rheumatology (Oxford). 2020;59:2443–7.

    Article  Google Scholar 

  114. Mustafa KN, Hadidy A, Joudeh A, Obeidat FN, Abdulfattah KW. Spinal cord infarction in giant cell arteritis associated with scalp necrosis. Rheumatol Int. 2015;35(2):377–81.

    Article  PubMed  Google Scholar 

  115. Galetta SL, Balcer LJ, Lieberman AP, Syed NA, Lee JM, Oberholtzer JC. Refractory giant cell arteritis with spinal cord infarction. Neurology. 1997;49(6):1720–3.

    Article  CAS  PubMed  Google Scholar 

  116. Zalewski NL, Rabinstein AA, Krecke KN, Brown RD Jr, Wijdicks EFM, Weinshenker BG, et al. Characteristics of spontaneous spinal cord infarction and proposed diagnostic criteria. JAMA Neurol. 2019;76(1):56–63.

    Article  PubMed  Google Scholar 

  117. Dubey D, Pittock SJ, Krecke KN, Morris PP, Sechi E, Zalewski NL, et al. Clinical, radiologic, and prognostic features of myelitis associated with myelin oligodendrocyte glycoprotein autoantibody. JAMA Neurol. 2019;76(3):301–9.

    Article  PubMed  Google Scholar 

  118. Sechi E, Krecke KN, Pittock SJ, Dubey D, Lopez-Chiriboga AS, Kunchok A, et al. Frequency and characteristics of MRI-negative myelitis associated with MOG autoantibodies. Mult Scler. 2020;1352458520907900.

  119. Kim HA, Kim JH, Won JH, Suh CH. An unusual clinical manifestation of Takayasu's arteritis: spinal cord compression. Joint Bone Spine. 2009;76(2):209–12.

    Article  PubMed  Google Scholar 

  120. Staud R, Williams RC Jr. Brain abscess mimicking giant cell (temporal) arteritis. Arthritis Rheum. 1995;38(11):1710–2.

    Article  CAS  PubMed  Google Scholar 

  121. Na S, Lee ES, Kim YD. Teaching NeuroImages: pterygoid myositis mimicking giant cell arteritis. Neurology. 2019;92(19):e2297.

    Article  PubMed  Google Scholar 

  122. Al-Absi AI, Wall BM, Cooke CR. Medial arterial calcification mimicking temporal arteritis. Am J Kidney Dis. 2004;44(4):e73–8.

    Article  PubMed  Google Scholar 

  123. Narayan N, Bennett P, Chan C, Rhodes B. Secondary syphilis mimicking giant cell arteritis. J Clin Rheumatol. 2020;26(1):18–20.

    Article  PubMed  Google Scholar 

  124. Hayreh SS, Podhajsky PA, Zimmerman B. Occult giant cell arteritis: ocular manifestations. Am J Ophthalmol. 1998;125(4):521–6.

    Article  CAS  PubMed  Google Scholar 

  125. Chen JJ, Leavitt JA, Fang C, Crowson CS, Matteson EL, Warrington KJ. Evaluating the incidence of arteritic ischemic optic neuropathy and other causes of vision loss from giant cell arteritis. Ophthalmology. 2016;123(9):1999–2003.

    Article  PubMed  Google Scholar 

  126. Arnold AC. Pathogenesis of nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol. 2003;23(2):157–63.

    Article  PubMed  Google Scholar 

  127. Kale N, Eggenberger E. Diagnosis and management of giant cell arteritis: a review. Curr Opin Ophthalmol. 2010;21(6):417–22.

    Article  PubMed  Google Scholar 

  128. Karam EZ, Muci-Mendoza R, Hedges TR 3rd. Retinal findings in Takayasu's arteritis. Acta Ophthalmol Scand. 1999;77(2):209–13.

    Article  CAS  PubMed  Google Scholar 

  129. Schmidt MH, Fox AJ, Nicolle DA. Bilateral anterior ischemic optic neuropathy as a presentation of Takayasu's disease. J Neuroophthalmol. 1997;17(3):156–61.

    Article  CAS  PubMed  Google Scholar 

  130. Chen JJ, Pittock SJ, Flanagan EP, Lennon VA, Bhatti MT. Optic neuritis in the era of biomarkers. Surv Ophthalmol. 2020;65(1):12–7.

    Article  PubMed  Google Scholar 

  131. Asseyer S, Hamblin J, Messina S, Mariano R, Siebert N, Everett R, et al. Prodromal headache in MOG-antibody positive optic neuritis. Mult Scler Relat Disord. 2020;40:101965.

    Article  PubMed  Google Scholar 

  132. Chen JJ, Flanagan EP, Jitprapaikulsan J, Lopez-Chiriboga ASS, Fryer JP, Leavitt JA, et al. Myelin oligodendrocyte glycoprotein antibody-positive optic neuritis: clinical characteristics, radiologic clues, and outcome. Am J Ophthalmol. 2018;195:8–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  133. Morgenstern KE, Ellis BD, Schochet SS, Linberg JV. Bilateral optic nerve sheath enhancement from giant cell arteritis. J Rheumatol. 2003;30(3):625–7.

    PubMed  Google Scholar 

  134. Chen JJ, Kardon RH, Daley TJ, Longmuir RA. Enhancement of the optic nerve sheath and temporal arteries from giant cell arteritis. Can J Ophthalmol. 2015;50(5):e96–7.

    Article  PubMed  Google Scholar 

  135. Ross M, Bursztyn L, Superstein R, Gans M. Multiple cranial nerve palsies in giant cell arteritis. J Neuroophthalmol. 2017;37(4):398–400.

    Article  PubMed  Google Scholar 

  136. Ross AG, Jivraj I, Rodriguez G, Pistilli M, Chen JJ, Sergott RC, et al. Retrospective, multicenter comparison of the clinical presentation of patients presenting with diplopia from giant cell arteritis vs other causes. J Neuroophthalmol. 2019;39(1):8–13.

    Article  PubMed  Google Scholar 

  137. Mantero V, Rigamonti A, Bianchi G, Piamarta F, Rossi G, Pozzetti U, et al. Pitfall in neurology: giant cell arteritis mimicking ocular myasthenia gravis. Neurol Sci. 2015;36(4):665–6.

    Article  PubMed  Google Scholar 

  138. Tripodaki ES, Kakavas S, Skrapari I, Michas D, Katsikas G, Kouvidou C, et al. Myasthenia gravis and stroke in the setting of giant cell arteritis. Case Rep Rheumatol. 2013;2013:505686.

    PubMed  PubMed Central  Google Scholar 

  139. Gilhus NE, Verschuuren JJ. Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol. 2015;14(10):1023–36.

    Article  CAS  PubMed  Google Scholar 

  140. Hendricks TM, Bhatti MT, Hodge DO, Chen JJ. Incidence, epidemiology, and transformation of ocular myasthenia gravis: a population-based study. Am J Ophthalmol. 2019;205:99–105.

    Article  PubMed  PubMed Central  Google Scholar 

  141. Taylan A, Karakas B, Gulcu A, Birlik M. Bilateral orbital pseudotumor in a patient with Takayasu arteritis: a case report and review of the literature. Rheumatol Int. 2016;36(5):743–6.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alvise Berti.

Ethics declarations

Conflict of Interest

The authors have no financial or non-financial potential conflicts of interest to declare related to this project. All the authors were involved in the writing and editing of the manuscript, and approved the final version to be published.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Recent Advances in Large Vessel Vasculitis

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Berti, A., Moura, M.C., Sechi, E. et al. Beyond Giant Cell Arteritis and Takayasu’s Arteritis: Secondary Large Vessel Vasculitis and Vasculitis Mimickers. Curr Rheumatol Rep 22, 88 (2020). https://doi.org/10.1007/s11926-020-00965-w

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11926-020-00965-w

Keywords

Navigation